𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Carrier cell-mediated cell lysis of squamous cell carcinoma cells by squamous cell carcinoma antigen 1 promoter-driven oncolytic adenovirus

✍ Scribed by Katsuyuki Hamada; Ting Zhang; Junzo Desaki; Koh-ichi Nakashiro; Hiroshi Itoh; Kenzaburo Tani; Yoshiyuki Koyama; Hiroyuki Hamakawa

Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
211 KB
Volume
12
Category
Article
ISSN
1099-498X

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Background

The squamous cell carcinoma antigen (SCCA) serves as a serological marker for squamous cell carcinomas. Molecular cloning of the SCCA genomic region has revealed the presence of two tandemly arrayed genes: SCCA1 and SCCA2. SCCA1 gene is up‐regulated in squamous cell carcinoma cells. We analyzed the proximal region of the SCCA1 promoter and the antitumor effect of oncolytic adenovirus driven by the SCCA1 promoter in squamous cell carcinoma cells.

Methods

The SCCA1 promoter was analyzed by dual luciferase assay and substituted with the E1A promoter to construct the oncolytic adenovirus to determine the squamous cell carcinoma‐specific cell lysis.

Results

Deletion analysis of SCCA1 promoter identified a 175‐bp core promoter region and an enhancer region at −525 to −475 bp upstream of the transcription start site. The transcriptional activity of the SCCA1 promoter was up‐regulated in squamous cell carcinoma cells. Five tandem repeats of enhancer increased SCCA1 promoter activity by four‐fold. Oncolytic adenovirus driven by this SCCA1 enhancer‐promoter complex specifically killed squamous cell carcinoma cells in vitro and in vivo. A549 carrier cells infected with the oncolytic adenovirus induced complete regression of syngeneic squamous cell carcinoma cell tumor by overcoming immunogenicity and adenovirus‐mGM‐CSF augmented the antitumor effect of carrier cells.

Conclusions

SCCA1 was up‐regulated in squamous cell carcinoma cells and oncolytic adenovirus driven by SCCA1 promoter specifically killed these cells. These findings suggest that SCCA1 promoter is a potential target of gene therapy for squamous cell carcinoma. Copyright © 2010 John Wiley & Sons, Ltd.

📜 SIMILAR VOLUMES

Role of squamous cell carcinoma antigen
Role of squamous cell carcinoma antigen 1 expression in the invasive potential of head and neck squamous cell carcinoma
✍ Torahiko Nakashima; Ryuji Yasumatsu; Yuichiro Kuratomi; Muneyuki Masuda; Takashi 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB 👁 2 views

## Background: Serine proteases have important roles in tumor invasion and metastasis, and their inhibitors, serine protease inhibitors (serpins), are attractive targets for therapeutic strategies. on chromosome 18q21, there is a cluster of serpins: maspin, headpin, and squamous cell carcinoma anti

T-cell receptor Vβ gene usage by T cells
T-cell receptor Vβ gene usage by T cells reactive with the tumor-rejection antigen SART-1 in oral squamous cell carcinoma
✍ Wataru Kumamaru; Seiji Nakamura; Tsutomu Kadena; Akira Yamada; Eiji Kawamura; Ma 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 425 KB

## Abstract We recently described that the SART‐1~690–698~ peptide could induce HLA‐A24‐restricted cytotoxic T lymphocytes (CTLs), which recognize the SART‐1 tumor cells from peripheral blood mononuclear cells (PBMCs) of HLA‐A24^+^ cancer patients. In our study, in 5 of 14 HLA‐A24^+^ patients with

Enhanced susceptibility of oral squamous
Enhanced susceptibility of oral squamous cell carcinoma cell lines to FAS-mediated apoptosis by cisplatin and 5-fluorouracil
✍ Masayasu Iwase; Hitoshi Watanabe; Gen Kondo; Masaru Ohashi; Masao Nagumo 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 263 KB 👁 1 views

## Abstract Our study was conducted to investigate whether anticancer drugs, cisplatin (CDDP) and/or 5‐fluorouracil (5‐FU), can modulate Fas‐mediated apoptosis in oral squamous cell carcinoma (OSCC) cell lines. When OSCC cell lines, NA and HSC‐4, were treated with CDDP and/or 5‐FU, Fas and its mRNA